Home NDC 69543-121 ACARBOSE
Product NDC 69543-121
11-digit product format 695430121
Labeler code 69543
Product ID 69543-121_2fe4e6ff-b000-436f-9a4c-530a190f081f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACARBOSE
Dosage form TABLET
Route ORAL
Labeler Virtus Pharmaceuticals LLC
Application ANDA091343
Marketing category ANDA
Marketing start 2015-02-01
Marketing end 0000-00-00
Substance ACARBOSE
Active strength 50 mg/1
Pharmacologic classes alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 27 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091343-001 ACARBOSE ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 A091343-002 ACARBOSE ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 A091343-003 ACARBOSE ACARBOSE 100MG TABLET / ORAL AB 2013-10-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091343-002 ACARBOSE 50MG TABLET / ORAL AB 2013-10-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091343-003 ACARBOSE 100MG TABLET / ORAL AB 2013-10-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091343-001 ACARBOSE 25MG TABLET / ORAL AB 2013-10-17 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded acarbose ACTIVE INGREDIENT T58MSI464G ACARBOSE (ACARBOSE) TABLET [AVKARE, INC.] 3 acarbose ACTIVE MOIETY T58MSI464G ACARBOSE (ACARBOSE) TABLET [AVKARE, INC.] 3 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ACARBOSE (ACARBOSE) TABLET [AVKARE, INC.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ACARBOSE (ACARBOSE) TABLET [AVKARE, INC.] 3 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ACARBOSE (ACARBOSE) TABLET [AVKARE, INC.] 3 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ACARBOSE (ACARBOSE) TABLET [AVKARE, INC.] 3 acarbose ACTIVE INGREDIENT T58MSI464G ACARBOSE TABLET [VIRTUS PHARMACEUTICALS LLC] 2 acarbose ACTIVE MOIETY T58MSI464G ACARBOSE TABLET [VIRTUS PHARMACEUTICALS LLC] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ACARBOSE TABLET [VIRTUS PHARMACEUTICALS LLC] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ACARBOSE TABLET [VIRTUS PHARMACEUTICALS LLC] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ACARBOSE TABLET [VIRTUS PHARMACEUTICALS LLC] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ACARBOSE TABLET [VIRTUS PHARMACEUTICALS LLC] 2
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69543-121-10 69543012110 100 TABLET in 1 BOTTLE (69543-121-10) 100 tablet 2015-02-01 0000-00-00 No No Current 69543-121-11 69543012111 1000 TABLET in 1 BOTTLE (69543-121-11) 1000 tablet 2015-02-01 0000-00-00 No No Current